Stavudine Clinical Trials

• A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination with Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
  ClinicalTrials.gov Identifier: NCT00000878 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00000901 - Active, not recruiting
  HIV Infections
  
• Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00006397 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002451 - Active, not recruiting
  HIV Infections
  
• A Comparison of Emtricitabine and Stavudine Used with Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00006208 - Active, not recruiting
  HIV Infections
  
• Study of Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination with Lamivudine and Efavirenz Vs. Stavudine, Lamivudine and Efavirenz.
  ClinicalTrials.gov Identifier: NCT00158821 - Active, not recruiting
  HIV-1
  
• Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY
  ClinicalTrials.gov Identifier: NCT00235222 - Active, not recruiting
  HIV
  
• A Study of HIV-Disease Development in Aging
  ClinicalTrials.gov Identifier: NCT00006144 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
  ClinicalTrials.gov Identifier: NCT00002241 - Active, not recruiting
  HIV Infections
  
• A Study to Compare Two Different Anti-HIV Drug Regimens
  ClinicalTrials.gov Identifier: NCT00000924 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients
  ClinicalTrials.gov Identifier: NCT00007202 - Active, not recruiting
  HIV Infections
  
• Treatment with Combinations of Several Antiviral Drugs in Infants and Young Children with HIV Infection
  ClinicalTrials.gov Identifier: NCT00000872 - Active, not recruiting
  HIV Infections
  
• Treatment with Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328
  ClinicalTrials.gov Identifier: NCT00000923 - Active, not recruiting
  HIV Infections
  
• A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients between Ages 4 and 22 with 7 Drugs, Some at Higher than Usual Doses
  ClinicalTrials.gov Identifier: NCT00001108 - Active, not recruiting
  HIV Infections
  
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
  ClinicalTrials.gov Identifier: NCT00050895 - Active, not recruiting
  HIV Infections
  
• A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation
  ClinicalTrials.gov Identifier: NCT00036452 - Active, not recruiting
  HIV Infections
  
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children with Prior Treatment
  ClinicalTrials.gov Identifier: NCT00000902 - Active, not recruiting
  HIV Infections
  
• A Study of ABT-378/Ritonavir in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00004578 - Active, not recruiting
  HIV Infections
  
• Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected with HIV
  ClinicalTrials.gov Identifier: NCT00000940 - Active, not recruiting
  HIV Infections
  
• Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa
  ClinicalTrials.gov Identifier: NCT00100646 - Active, not recruiting
  HIV Infections
  
• A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.
  ClinicalTrials.gov Identifier: NCT00002349 - Completed
  HIV Infections
  
• Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
  ClinicalTrials.gov Identifier: NCT00471614 - Recruiting
  HIV Infections; Insulin Resistance; Hyperlactatemia
  
• Treatment with Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00005000 - Active, not recruiting
  HIV Infections
  
• Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00005918 - Completed
  HIV Infections
  
• Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
  ClinicalTrials.gov Identifier: NCT00312091 - Recruiting
  HIV Infections
  
• Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children (Ages 2- <12)
  ClinicalTrials.gov Identifier: NCT00528957 - Recruiting
  HIV Infections
  
• Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)
  ClinicalTrials.gov Identifier: NCT00116298 - Completed
  HIV Infections; AIDS
  
• Study of Anti-HIV Therapy Intensification
  ClinicalTrials.gov Identifier: NCT00034086 - Active, not recruiting
  HIV Infections
  
• A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002308 - Completed
  HIV Infections
  
• When to Start Anti-HIV Drugs in Patients with Opportunistic Infections
  ClinicalTrials.gov Identifier: NCT00055120 - Active, not recruiting
  HIV Infections; AIDS-Related Opportunistic Infections
  
• A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-deoxythymidine (Stavudine; d4T) in Children With HIV Infection
  ClinicalTrials.gov Identifier: NCT00000789 - Completed
  HIV Infections
  
• Comparison of Stavudine Used Alone or in Combination with Didanosine in HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00000851 - Completed
  HIV Infections
  
• A Comparison of Two Dose Levels of Didanosine Used in Combination with Stavudine in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002207 - Completed
  HIV Infections
  
• Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
  ClinicalTrials.gov Identifier: NCT00005017 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Combining Hydroxyurea (HU) with Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults
  ClinicalTrials.gov Identifier: NCT00002427 - Completed
  HIV Infections
  
• Evaluation of Four Anti-HIV Treatment Strategies in Resource-Limited South African Communities
  ClinicalTrials.gov Identifier: NCT00255840 - Active, not recruiting
  HIV Infections
  
• A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002230 - Completed
  HIV Infections
  
• Emtricitabine Given Once A Day with Other Anti-HIV Drugs in Children with HIV
  ClinicalTrials.gov Identifier: NCT00017992 - Recruiting
  HIV Infections
  
• The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine
  ClinicalTrials.gov Identifier: NCT00002381 - Completed
  HIV Infections
  
• A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002307 - Completed
  HIV Infections
  
• The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine
  ClinicalTrials.gov Identifier: NCT00002371 - Completed
  HIV Infections
  
• A Study of Efavirenz in Combination with Stavudine and Didanosine
  ClinicalTrials.gov Identifier: NCT00002225 - Completed
  HIV Infections
  
• A Pilot Open Label Trial of HIV Therapy with d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects with Early Asymptomatic HIV Infection
  ClinicalTrials.gov Identifier: NCT00002176 - Completed
  HIV Infections
  
• Antiviral Activity of and Resistance to Lamivudine in Combination with Zidovudine, Stavudine, or Didanosine
  ClinicalTrials.gov Identifier: NCT00000838 - Completed
  HIV Infections
  
• A Pilot Open Label Trial of HIV Therapy with d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects with Recent HIV Infection
  ClinicalTrials.gov Identifier: NCT00002177 - Completed
  HIV Infections
  
• Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination with Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
  ClinicalTrials.gov Identifier: NCT00000882 - Completed
  HIV Infections
  
• The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined with Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002379 - Completed
  HIV Infections
  
• A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients
  ClinicalTrials.gov Identifier: NCT00002354 - Completed
  HIV Infections
  
• A Study to Compare the Safety and Effectiveness of Indinavir Combined with Stavudine and Lamivudine
  ClinicalTrials.gov Identifier: NCT00002424 - Suspended
  HIV Infections
  
• A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
  ClinicalTrials.gov Identifier: NCT00002246 - Completed
  AIDS Dementia Complex; HIV Infections
  
• A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
  ClinicalTrials.gov Identifier: NCT00006154 - Not yet recruiting
  HIV Infections
  
• The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined with MKC-442 in HIV-Infected Patients Who Have Not Had Success with Protease Inhibitors
  ClinicalTrials.gov Identifier: NCT00002418 - Terminated
  HIV Infections
  
• The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success with Protease Inhibitors
  ClinicalTrials.gov Identifier: NCT00002420 - Terminated
  HIV Infections
  
• 2NN & CHARM Long-Term Follow-Up Study
  ClinicalTrials.gov Identifier: NCT00127972 - Completed
  HIV-1
  
• Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00312832 - Completed
  HIV Infections; Lipoatrophy
  
• Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy
  ClinicalTrials.gov Identifier: NCT00000831 - Completed
  HIV Infections
  
• A Study of MKC-442 in Combination with Other Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002412 - Completed
  HIV Infections
  
• A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
  ClinicalTrials.gov Identifier: NCT00002430 - Completed
  HIV Infections
  
• A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated with Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002411 - Completed
  HIV Infections
  
• Study of a New Protease Inhibitor, BMS-232632, in Combination with Other Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002240 - Completed
  HIV Infections
  
• A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy with Combination Ritonavir, Nevirapine and Stavudine
  ClinicalTrials.gov Identifier: NCT00001688 - Completed
  HIV Infection
  
• A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002168 - Completed
  HIV Infections
  
• A Study of BMY-27857 in Patients with AIDS or AIDS Related Complex
  ClinicalTrials.gov Identifier: NCT00000988 - Completed
  HIV Infections
  
• A Comparison of Epivir Plus Crixivan Combined with Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002369 - Completed
  HIV Infections
  
• A Comparison of Two Drug Combinations Used in HIV-Infected Patients Who Never Have Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00005573 - Completed
  HIV Infections
  
• Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens
  ClinicalTrials.gov Identifier: NCT00001091 - Completed
  HIV Infections
  
• A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly
  ClinicalTrials.gov Identifier: NCT00001122 - Completed
  HIV Infections
  
• A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated with Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002407 - Completed
  HIV Infections
  
• A Study on the Effect of Chemotherapy Combined with Anti-HIV Drugs in HIV-Positive Patients
  ClinicalTrials.gov Identifier: NCT00000899 - Completed
  HIV Infections
  
• The Safety and Effects of 1592U89 Used Alone or in Combination with Other Anti-HIV Drugs in HIV-Infected Infants and Children
  ClinicalTrials.gov Identifier: NCT00000865 - Completed
  HIV Infections
  
• A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible
  ClinicalTrials.gov Identifier: NCT00000939 - Completed
  HIV Infections
  
• The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002376 - Completed
  HIV Infections
  
• Comparison of Two Anti-HIV Regimens that Include One of Two Forms of Didanosine (ddI)
  ClinicalTrials.gov Identifier: NCT00002224 - Completed
  HIV Infections
  
• The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More than 12 Weeks
  ClinicalTrials.gov Identifier: NCT00001063 - Completed
  HIV Infections
  
• A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir
  ClinicalTrials.gov Identifier: NCT00001095 - Completed
  HIV Infections
  
• A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination with Two Other Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002442 - Completed
  HIV Infections
  
• A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs
  ClinicalTrials.gov Identifier: NCT00002162 - Completed
  HIV Infections
  
• Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002211 - Completed
  HIV Infections
  
• A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00005106 - Completed
  HIV Infections
  
• A Study of Saquinavir Soft Gelatin Capsules Combined with Other Anti-HIV Drugs in HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00002374 - Completed
  HIV Infections
  
• A Study to determine how and why HIV-Infected subjects on anti-viral treatment develop Lipodystrophy
  ClinicalTrials.gov Identifier: NCT00006190 - Completed
  HIV Infections; Lipodystrophy
  
• A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002227 - Completed
  HIV Infections
  
• Effects of Ribavirin on Zidovudine or Stavudine
  ClinicalTrials.gov Identifier: NCT00021632 - Completed
  HIV Infections; Hepatitis C
  
• Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00001083 - Completed
  HIV Infections
  
• The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00001067 - Completed
  HIV Infections
  
• Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00004855 - Completed
  HIV Infections
  
• Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects with Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315
  ClinicalTrials.gov Identifier: NCT00000891 - Completed
  HIV Infections
  
• Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients with Tuberculosis
  ClinicalTrials.gov Identifier: NCT00004736 - Completed
  HIV Infections; Tuberculosis
  
• DART II - Study of 3 Antiretroviral Medicines in Combination, in HIV Patients who Have Not Been Previously Treated with Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00116116 - Completed
  HIV Infections; AIDS
  
• A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00002378 - Completed
  HIV Infections
  
• A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Treatments in HIV-Positive Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)
  ClinicalTrials.gov Identifier: NCT00000922 - Completed
  HIV Infections
  
• Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection
  ClinicalTrials.gov Identifier: NCT00006443 - Completed
  HIV Infections
  
• Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males with Hemophilia
  ClinicalTrials.gov Identifier: NCT00002386 - Completed
  HIV Infections; Hemophilia A
  
• Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen
  ClinicalTrials.gov Identifier: NCT00014937 - Completed
  HIV Infections
  
• Strategies for Delivering Anti-HIV Therapy in South Africa
  ClinicalTrials.gov Identifier: NCT00080522 - Completed
  HIV Infections
  
• A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination with GM-CSF or IL-12 to HIV-Positive Patients
  ClinicalTrials.gov Identifier: NCT00000896 - Completed
  HIV Infections
  
• Preventing Sexual Transmission of HIV With Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00074581 - Completed
  HIV Infections; HIV Seronegativity
  
• A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00001084 - Completed
  HIV Infections
  
• Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination with Nucleoside Analogs: A Rollover Study for ACTG 320
  ClinicalTrials.gov Identifier: NCT00000885 - Completed
  HIV Infections
  
• Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen
  ClinicalTrials.gov Identifier: NCT00002429 - Completed
  HIV Infections